Mirae Asset Global Investments
ITCI

Mirae Asset Global Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Mirae Asset Global Investments’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,560
Closed -$469K – 1663
2025
Q1 		$469K Buy
3,560
+27
+0.8% +$3.37K ﹤0.01% 937
2024
Q4 		$300K Sell
3,533
-289
-8% -$23.7K ﹤0.01% 1006
2024
Q3 		$280K Buy
3,822
+670
+21% +$50.4K ﹤0.01% 1034
2024
Q2 		$224K Sell
3,152
-40,602
-93% -$2.82M ﹤0.01% 1037
2024
Q1 		$2.48M Sell
43,754
-1,875
-4% -$129K 0.01% 1090
2023
Q4 		$3.27M Buy
45,629
+146
+0.3% +$8.4K 0.01% 1050
2023
Q3 		$2.37M Buy
45,483
+2,434
+6% +$142K 0.01% 1110
2023
Q2 		$2.73M Sell
43,049
-167
-0.4% -$10.4K 0.01% 1067
2023
Q1 		$2.34M Sell
43,216
-61
-0.1% -$2.95K 0.01% 1141
2022
Q4 		$2.29M Sell
43,277
-1,374
-3% -$68.9K 0.01% 1084
2022
Q3 		$2.08M Buy
44,651
+14,482
+48% +$757K 0.01% 1113
2022
Q2 		$1.72M Buy
+30,169
New +$1.71M ﹤0.01% 1185

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global Investments's ITCI Position: Q2 2025 in Review

Mirae Asset Global Investments sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,560 shares — an estimated $469K sold.

Mirae Asset Global Investments first reported a position in ITCI in Q2 2022 and held it in 12 quarters. The position peaked at $3.27M in Q4 2023. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Mirae Asset Global Investments reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,560 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $469K.
  • Mirae Asset Global Investments first reported a position in Intra-Cellular Therapies Inc. in Q2 2022 and held it in 12 quarters.
  • Mirae Asset Global Investments's Intra-Cellular Therapies Inc. position peaked at $3.27M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.